Keval Desai's Net Worth
$380 Million
Who is Keval Desai?
Keval Desai has an estimated net worth of $380 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, TESARO, Inc., Doximity, Inc., Invuity, Inc., PMV Pharmaceuticals, Inc., Braze, Inc., Eiger BioPharmaceuticals, Inc., and OBALON THERAPEUTICS INC.
SEC CIK
Keval Desai's CIK is 0001553019
Past Insider Trading and Trends
2021 was Keval Desai's most active year for acquiring shares with 25 total transactions. Keval Desai's most active month to acquire stocks was the month of August. 2021 was Keval Desai's most active year for disposing of shares, totalling 23 transactions. Keval Desai's most active month to dispose stocks was the month of October. 2012 saw Keval Desai paying a total of $5,999,994.00 for 3,071,701 shares, this is the most they've acquired in one year. In 2021 Keval Desai cashed out on 62,836,091 shares for a total of $174,791,472.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVEDRO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.75M |
—
|
—
|
0
|
Nov 21
| |||
Form 4
| +2,598.74% | 2.64M |
—
|
—
| 2.74M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TESARO, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.53% | -600.00K |
—
|
—
| 2.47M |
Aug 5
| |||
Form 4
|
∞
| 3.07M |
$13.50 |
—
| 3.07M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Doximity, Inc. (DOCS) Snapshot price: $27.405
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.09% | 68.6K |
—
|
—
| 136.45K |
Dec 2
| |||
Form 4
|
∞
| 67.86K |
—
|
—
| 67.86K |
Nov 12
| |||
Form 4
|
—
|
0
|
$24.57 | -$105,386,872.50 |
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Invuity, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.08M |
—
|
—
| 1.08M |
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.48% | -471.77K |
—
|
—
| 4.5M |
Jul 13
| |||
Form 4
| -9.11% | -498.55K |
—
|
—
| 4.97M |
May 10
| |||
Form 4
| -15.41% | -1.00M |
—
|
—
| 5.47M |
Mar 24
| |||
Form 4/A
|
∞
| 6.47M |
$18.00 |
—
| 6.47M |
Sep 25 - Sep 29
| |||
Form 4
| +11,762.47% | 6.47M |
$18.00 | $990,000.00 | 6.52M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |